JP2024514182A5 - - Google Patents
Info
- Publication number
- JP2024514182A5 JP2024514182A5 JP2023563061A JP2023563061A JP2024514182A5 JP 2024514182 A5 JP2024514182 A5 JP 2024514182A5 JP 2023563061 A JP2023563061 A JP 2023563061A JP 2023563061 A JP2023563061 A JP 2023563061A JP 2024514182 A5 JP2024514182 A5 JP 2024514182A5
- Authority
- JP
- Japan
- Prior art keywords
- mrna
- vaccine according
- antigenic polypeptide
- encoding
- respiratory viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163174463P | 2021-04-13 | 2021-04-13 | |
| US63/174,463 | 2021-04-13 | ||
| US202163175011P | 2021-04-14 | 2021-04-14 | |
| US63/175,011 | 2021-04-14 | ||
| US202163241959P | 2021-09-08 | 2021-09-08 | |
| US63/241,959 | 2021-09-08 | ||
| US202263322121P | 2022-03-21 | 2022-03-21 | |
| US63/322,121 | 2022-03-21 | ||
| PCT/US2022/024497 WO2022221335A1 (en) | 2021-04-13 | 2022-04-12 | Respiratory virus combination vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514182A JP2024514182A (ja) | 2024-03-28 |
| JP2024514182A5 true JP2024514182A5 (cg-RX-API-DMAC10.html) | 2025-04-17 |
Family
ID=81449216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563061A Pending JP2024514182A (ja) | 2021-04-13 | 2022-04-12 | 呼吸器ウイルス組み合わせワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240216500A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4322993A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024514182A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022258335A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022221335A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20220070T1 (hr) | 2014-04-23 | 2022-04-01 | Modernatx, Inc. | Cjepiva nukleinske kiseline |
| EP3328394A4 (en) | 2015-07-30 | 2019-03-13 | ModernaTX, Inc. | CONCATEMEE peptide epitope RNAs |
| DE20164728T1 (de) | 2015-10-22 | 2021-09-30 | Modernatx, Inc. | Impfstoffe gegen atemwegsvirus |
| EP3364949A4 (en) | 2015-10-22 | 2019-07-31 | ModernaTX, Inc. | CANCER VACCINES |
| US12128113B2 (en) | 2016-05-18 | 2024-10-29 | Modernatx, Inc. | Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome |
| SG11201901941YA (en) | 2016-09-14 | 2019-04-29 | Modernatx Inc | High purity rna compositions and methods for preparation thereof |
| MA46766A (fr) | 2016-11-11 | 2019-09-18 | Modernatx Inc | Vaccin antigrippal |
| WO2018170270A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Varicella zoster virus (vzv) vaccine |
| WO2018170256A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Herpes simplex virus vaccine |
| MA48047A (fr) | 2017-04-05 | 2020-02-12 | Modernatx Inc | Réduction ou élimination de réponses immunitaires à des protéines thérapeutiques administrées par voie non intraveineuse, par exemple par voie sous-cutanée |
| MA49421A (fr) | 2017-06-15 | 2020-04-22 | Modernatx Inc | Formulations d'arn |
| EP3668977A4 (en) | 2017-08-18 | 2021-04-21 | Modernatx, Inc. | HPLC ANALYTICAL PROCESSES |
| WO2019036682A1 (en) | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | RNA VARIANTS POLYMERASE |
| MX2020002348A (es) | 2017-08-31 | 2020-10-08 | Modernatx Inc | Métodos de elaboración de nanopartículas lipídicas. |
| US11911453B2 (en) | 2018-01-29 | 2024-02-27 | Modernatx, Inc. | RSV RNA vaccines |
| CN112996854B (zh) | 2018-09-19 | 2024-08-30 | 摩登纳特斯有限公司 | 高纯度peg脂质和其用途 |
| US12151029B2 (en) | 2018-09-19 | 2024-11-26 | Modernatx, Inc. | PEG lipids and uses thereof |
| US12090235B2 (en) | 2018-09-20 | 2024-09-17 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| CN113939282A (zh) | 2019-01-31 | 2022-01-14 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
| MX2021010075A (es) | 2019-02-20 | 2021-12-10 | Modernatx Inc | Variantes de arn polimerasa para la formacion de casquetes cotranscripcionales. |
| MX2021011031A (es) | 2019-03-11 | 2021-12-10 | Modernatx Inc | Proceso de transcripción in vitro en lotes alimentados. |
| MA55321A (fr) | 2019-03-15 | 2022-01-19 | Modernatx Inc | Vaccins à base d'arn contre le vih |
| WO2022150717A1 (en) | 2021-01-11 | 2022-07-14 | Modernatx, Inc. | Seasonal rna influenza virus vaccines |
| US20220363937A1 (en) | 2021-05-14 | 2022-11-17 | Armstrong World Industries, Inc. | Stabilization of antimicrobial coatings |
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| US12529047B1 (en) | 2021-12-21 | 2026-01-20 | Modernatx, Inc. | mRNA quantification methods |
| US11878055B1 (en) | 2022-06-26 | 2024-01-23 | BioNTech SE | Coronavirus vaccine |
| EP4642481A2 (en) * | 2022-12-29 | 2025-11-05 | Popvax Private Limited | Multitarget vaccines and therapeutics |
| TW202438672A (zh) * | 2023-01-31 | 2024-10-01 | 美商亞克圖羅斯醫療公司 | 四價流感疫苗之方法及組成物 |
| CN121419787A (zh) * | 2023-06-28 | 2026-01-27 | 赛诺菲巴斯德有限公司 | 多价流感mRNA疫苗 |
| WO2025186719A1 (en) * | 2024-03-06 | 2025-09-12 | Pfizer Inc. | Immunogenic compositions and uses thereof |
| WO2026003577A1 (en) * | 2024-06-25 | 2026-01-02 | Popvax Private Limited | Multisubunit hepacivirus vaccines and therapeutics |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE291925T1 (de) | 2001-06-05 | 2005-04-15 | Curevac Gmbh | Stabilisierte mrna mit erhöhtem g/c-gehalt und optimierter codon usage für die gentherapie |
| US20090104226A1 (en) * | 2004-05-21 | 2009-04-23 | Novartis Vaccines And Diagnostics Inc. | Alphavirus Vectors for Respiratory Pathogen Vaccines |
| US9012219B2 (en) | 2005-08-23 | 2015-04-21 | The Trustees Of The University Of Pennsylvania | RNA preparations comprising purified modified RNA for reprogramming cells |
| DE102005046490A1 (de) | 2005-09-28 | 2007-03-29 | Johannes-Gutenberg-Universität Mainz | Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen |
| JP2010531640A (ja) | 2007-06-29 | 2010-09-30 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション | 毒性化合物の分解方法 |
| SG10201408164XA (en) | 2007-12-11 | 2015-01-29 | Scripps Research Inst | Compositions and methods related to mrna translational enhancer elements |
| WO2012104820A1 (en) * | 2011-02-04 | 2012-08-09 | Pfizer Inc. | Compositions for canine respiratory disease complex |
| KR20220025112A (ko) | 2011-06-08 | 2022-03-03 | 샤이어 휴먼 지네틱 테라피즈 인크. | Mrna 전달을 위한 지질 나노입자 조성물 및 방법 |
| EA201492055A1 (ru) | 2012-06-08 | 2015-11-30 | Шир Хьюман Дженетик Терапис, Инк. | ИНГАЛЯЦИОННАЯ ДОСТАВКА мРНК В НЕЛЕГОЧНЫЕ КЛЕТКИ-МИШЕНИ |
| ES2967701T3 (es) | 2013-03-15 | 2024-05-03 | Translate Bio Inc | Mejora sinergística de la entrega de ácidos nucleicos mediante formulaciones mezcladas |
| SG10201801428RA (en) | 2013-08-21 | 2018-03-28 | Curevac Ag | Method for increasing expression of rna-encoded proteins |
| WO2015062738A1 (en) | 2013-11-01 | 2015-05-07 | Curevac Gmbh | Modified rna with decreased immunostimulatory properties |
| CA2927254C (en) | 2013-12-30 | 2023-10-24 | Curevac Ag | Artificial nucleic acid molecules |
| AU2014375402B2 (en) | 2013-12-30 | 2020-10-01 | CureVac SE | Artificial nucleic acid molecules |
| DE20164728T1 (de) * | 2015-10-22 | 2021-09-30 | Modernatx, Inc. | Impfstoffe gegen atemwegsvirus |
| EP3405579A1 (en) | 2016-01-22 | 2018-11-28 | Modernatx, Inc. | Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof |
| KR20190093816A (ko) * | 2016-10-26 | 2019-08-26 | 큐어백 아게 | 지질 나노입자 mRNA 백신 |
| WO2019036682A1 (en) | 2017-08-18 | 2019-02-21 | Modernatx, Inc. | RNA VARIANTS POLYMERASE |
| MX2021010075A (es) | 2019-02-20 | 2021-12-10 | Modernatx Inc | Variantes de arn polimerasa para la formacion de casquetes cotranscripcionales. |
| WO2021239880A1 (en) * | 2020-05-29 | 2021-12-02 | Curevac Ag | Nucleic acid based combination vaccines |
| CN112546211A (zh) * | 2020-10-23 | 2021-03-26 | 嘉晨西海(杭州)生物技术有限公司 | 基于mRNA的针对冠状病毒和流感病毒的联合疫苗及其制备方法 |
-
2022
- 2022-04-12 WO PCT/US2022/024497 patent/WO2022221335A1/en not_active Ceased
- 2022-04-12 US US18/555,087 patent/US20240216500A1/en active Pending
- 2022-04-12 JP JP2023563061A patent/JP2024514182A/ja active Pending
- 2022-04-12 AU AU2022258335A patent/AU2022258335A1/en active Pending
- 2022-04-12 EP EP22720218.1A patent/EP4322993A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024513999A5 (cg-RX-API-DMAC10.html) | ||
| JP7817257B2 (ja) | mRNAワクチンを送達するための脂質ナノ粒子 | |
| US11771653B2 (en) | Lipid nanoparticles for delivering mRNA vaccines | |
| JP2024503698A5 (cg-RX-API-DMAC10.html) | ||
| EP4226938A2 (en) | Coronavirus vaccine | |
| JP6185548B2 (ja) | インフルエンザワクチンの製造方法 | |
| JP2011504486A5 (cg-RX-API-DMAC10.html) | ||
| CN116322758A (zh) | 基于核酸的组合疫苗 | |
| JPH11500409A (ja) | ワクチン組成物用アジュバント | |
| JP2009539965A5 (cg-RX-API-DMAC10.html) | ||
| RU2015132962A (ru) | Иммуногенные композиции на основе вируса гриппа и их применение | |
| TW201427686A (zh) | 改良之疫苗組成物及使用方法 | |
| US11878055B1 (en) | Coronavirus vaccine | |
| JP2015500854A5 (cg-RX-API-DMAC10.html) | ||
| WO2024191860A2 (en) | Nucleic acid influenza vaccines and respiratory virus combination vaccines | |
| US12208136B2 (en) | Coronavirus vaccine | |
| Chaparian et al. | A virion-based combination vaccine protects against influenza and SARS-CoV-2 disease in mice | |
| JP2024015475A (ja) | コロナウイルスワクチン | |
| JP2009514839A5 (cg-RX-API-DMAC10.html) | ||
| CN121038810A (zh) | 针对冠状病毒感染、流行性感冒感染和/或rsv感染的组合疫苗 | |
| CN116650633A (zh) | 冠状病毒疫苗 | |
| US20240366747A1 (en) | Universal vaccine for influenza virus based on tetrameric m2 protein incorporated into nanodiscs | |
| JP2011524372A (ja) | インフルエンザワクチン接種のための新規ペプチドアジュバント | |
| Jangra et al. | Sterilizing immunity against SARS-CoV-2 infection in mice by a single-shot and modified imidazoquinoline TLR7/8 agonist-adjuvanted recombinant spike protein vaccine | |
| TW202539697A (zh) | 冠狀病毒疫苗 |